Intrahepatic cholestasis of pregnancy – Diagnosis and management: A consensus statement of the Society of Obstetric Medicine of Australia and New Zealand ( SOMANZ ): Executive summary
Australian and New Zealand Journal of Obstetrics and Gynaecology · 2023-10 · 63 (5) · 656-665
DOI: 10.1111/ajo.13719 ↗Kurz gefasst
Leitlinie in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, online erschienen am 11.07.2023. Verfasst von William M Hague und 13 weiteren Autor:innen. Beteiligte Einrichtung: Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia. Hauptthemen laut MEDLINE: Cholestasis, Intrahepatic, Pregnancy Complications. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
KEY POINTS Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy liver disease, characterised by pruritus and increased total serum bile acids (TSBA), Australian incidence 0.6–0.7%. ICP is diagnosed by non‐fasting TSBA ≥ 19 μmol/L in a pregnant woman with pruritus without rash without a known pre‐existing liver disorder. Peak TSBA ≥ 40 and ≥ 100 μmol/L identify severe and very severe disease respectively, associated with spontaneous preterm birth when severe, and with stillbirth, when very severe. Benefit‐vs‐risk for iatrogenic preterm birth in ICP remains uncertain. Ursodeoxycholic acid remains the best pharmacotherapy preterm, improving perinatal outcome and reducing pruritus, although it has not been shown to reduce stillbirth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia.
- Women's Health & Midwifery Research, College of Nursing & Health Sciences, Bedford Park, South Australia, Australia.
- Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
- School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia.
- Department of Obstetrics and Gynaecology, Flinders Medical Centre, Bedford Park, South Australia, Australia.
- King Edward Memorial Hospital, Subiaco, Western Australia, Australia.
ORCID-Profile: William M Hague, Antonia Shand
Zitieren
APA
Hague, W. M., Briley, A., Callaway, L., Dekker Nitert, M., Gehlert, J., Graham, D., Grzeskowiak, L., Makris, A., Markus, C., Middleton, P., Peek, M. J., Shand, A., Stark, M., & Waugh, J. (2023). Intrahepatic cholestasis of pregnancy – Diagnosis and management: A consensus statement of the Society of Obstetric Medicine of Australia and New Zealand ( SOMANZ ): Executive summary. Australian and New Zealand Journal of Obstetrics and Gynaecology, 63(5), 656-665. https://doi.org/10.1111/ajo.13719
Vancouver
Hague WM, Briley A, Callaway L, Dekker Nitert M, Gehlert J, Graham D, et al. Intrahepatic cholestasis of pregnancy – Diagnosis and management: A consensus statement of the Society of Obstetric Medicine of Australia and New Zealand ( SOMANZ ): Executive summary. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2023;63(5):656-665. doi:10.1111/ajo.13719
BibTeX
@article{Hague2023,
author = {Hague, William M and Briley, Annette and Callaway, Leonie and Dekker Nitert, Marloes and Gehlert, Jessica and Graham, Dorothy and Grzeskowiak, Luke and Makris, Angela and Markus, Corey and Middleton, Philippa and Peek, Michael J and Shand, Antonia and Stark, Michael and Waugh, Jason},
title = {Intrahepatic cholestasis of pregnancy – Diagnosis and management: A consensus statement of the Society of Obstetric Medicine of Australia and New Zealand ( SOMANZ ): Executive summary},
journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
year = {2023},
volume = {63},
number = {5},
pages = {656--665},
doi = {10.1111/ajo.13719}
}
EUVIMED